fluquadri sh
aventis pharma - indonesia - haemagglutinin a/michigan/45/2015 x-275 (h1n1); haemagglutinin b/brisbane/60/2008 (victoria lineage); haemagglutinin b/phuket/3073/20-13 (yamagata lineage); haemaglutinin a/hongkong/4801/2014 x-263b (h3n2) - cairan injeksi - 30 ug ha total per 0.5 ml dos
fluquadri sh
aventis pharma - indonesia - haemagglutinin a/michigan/45/2015 x-275 (h1n1); haemagglutinin b/brisbane/60/2008 (victoria lineage); haemagglutinin b/phuket/3073/20-13 (yamagata lineage); haemaglutinin a/hongkong/4801/2014 x-263b (h3n2) - cairan injeksi - 30 ug ha total per 0.25 ml dos
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
fluquadri
aventis pharma - indonesia - cairan injeksi - 30mcg ha total per 0,25 ml dos
vivaxim
aventis pharma - indonesia - hepatitis a immunoglobulin human; salmonella typhi-immunogen - cairan injeksi
flagyl
aventis pharma - indonesia - metronidazole - infus - 5 mg/ml
hexaxim cairan injeksi
aventis pharma - indonesia - diphteria toxoid protein; fha; filamentous hemagglutinin; haemophilus influenzae b; hepatitis b surface antigen (hbs ag); inactivated polio virus type 1; inactivated polio virus type 2; inactivated polio virus type 3; pertussistoxoid med aluminiumhydroxid; tetanus toxoid - cairan injeksi
vivaxim
aventis pharma - indonesia - typhoid vi polysaccharide, inactivated hepatitis a virus - suspensi injeksi - 25 mcg /160 iu
flagyl
aventis pharma - indonesia - metronidazole - infus - 500 mg